Evidence map›Paper›PMID 18775956›Full record

ArticleHuman molecular genetics2008

Characterization of placental cholesterol transport: ABCA1 is a potential target for in utero therapy of Smith-Lemli-Opitz syndrome.

Marie L Lindegaard, Christopher A Wassif, Boris Vaisman, Marcelo Amar, Elizabeth V Wasmuth, Robert Shamburek, Lars B Nielsen, Alan T Remaley, Forbes D Porter

Open access · bronzeAbstract read
In one paragraph

Article in Human molecular genetics, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 72 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Disruption ofBone research · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. The Placenta as a Mediator of Stress Effects on Neurodevelopmental Reprogramming.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2016
    Review
  16. Article
  17. Article
  18. Liver X receptors, nervous system, and lipid metabolism.Journal of endocrinological investigation · 2013
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Marie L LindegaardSection on Molecular Dysmorphology, Eunice Kennedy Schriver National Institute of Child Health and Human Development, National Heart, Lung and Blood Institute, NIH, DHHS, Bethesda, MD, USA. marie.s.lindegaard@dadlnet.dk
Christopher A Wassif
Boris Vaisman
Marcelo Amar
Elizabeth V Wasmuth
Robert Shamburek
Lars B Nielsen
Alan T Remaley
Forbes D Porter
National Heart Lung and Blood Institute · USEunice Kennedy Shriver National Institute of Child Health and Human Development · USRigshospitalet · DK

Funding

Inborn Errors of Cholesterol SynthesisZIAHD000139 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI PORTER, FORBES · 2009 to 2019
$11.7M
Use Of Animal Models To Study Lipid Genes That Modulate AtherosclerosisZ01HL002058 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI REMALEY, ALAN THOMAS · 1996 to 2008
$5.8M
MOLECULAR MECHANISMS OF DYSMORPHOLOGYZ01HD000139 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI PORTER, FORBES DENNISON · 1997 to 2008
$2.8M
Lipoprotein Metabolism In Genetic DyslipoproteinemiasZ01HL002064 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI CANNON, RICHARD · 2002 to 2008
$223k
Intramural NIH HHS Z01 HD000139
6 · The paper itself

Abstract

Patients with Smith-Lemli-Opitz syndrome (SLOS) are born with multiple congenital abnormalities. Postnatal cholesterol supplementation is provided; however, it cannot correct developmental malformations due to in utero cholesterol deficit. Increased transport of cholesterol from maternal to fetal circulation might attenuate congenital malformations. The cholesterol transporters Abca1, Abcg1, and Sr-b1 are present in placenta; however, their potential role in placental transport remains undetermined. In mice, expression analyses showed that Abca1 and Abcg1 transcripts increased 2-3-fold between embryonic days 13.5 and 18.5 in placental tissue; whereas, Sr-b1 expression decreased. To examine the functional role of Abca1, Abcg1 and Sr-b1 we measured the maternal-fetal transfer of (14)C-cholesterol in corresponding mutant embryos. Disruption of either Abca1 or Sr-b1 decreased cholesterol transfer by approximately 30%. In contrast, disruption of the Abcg1 had no effect. Treatment of pregnant C57Bl/6 female mice with TO901317, an LXR-agonist, increased both Abca1 expression and maternal-fetal cholesterol transfer to the fetus. In an SLOS mouse model (Dhcr7(-/-)), which is incapable of de novo synthesis of cholesterol, in utero treatment with TO901317 resulted in increased cholesterol content in Dhcr7(-/-) embryos. Our data support the hypothesis that Abca1, and possibly Sr-b1, contributes to transport maternal cholesterol to the developing fetus. Furthermore, we show, as a proof of principle, that modulating maternal-fetal cholesterol transport has potential for in utero therapy of SLOS.

Indexed as

AnimalsATP Binding Cassette Transporter 1ATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily G, Member 1BenzenesulfonamidesBiological TransportCholesterolFemaleFluorocarbonsHumansHydrocarbons, FluorinatedLipoproteinsMiceMice, Inbred C57BLPlacentaPlacental CirculationABCA1 protein, humanABCG1 protein, mouseATP Binding Cassette Transporter 1ATP-Binding Cassette TransportersATP Binding Cassette Transporter, Subfamily G, Member 1BenzenesulfonamidesCholesterolFluorocarbonsHydrocarbons, FluorinatedLipoproteinsSulfonamidesT0901317

Identifiers

PMID18775956
PMCPMC2581429
OpenAlexW2148723164

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.